Resistance to Selective FGFR Inhibitors in <i>FGFR-</i> Driven Urothelial Cancer
Francesco Facchinetti(Inserm), Luc Friboulet(Inserm)
Cited by 69
Related Papers
The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer
|Cancer Discovery|2014|842
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
|Annals of Oncology|2022|138
Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1
|Translational Lung Cancer Research|2021|57
Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
|Lung Cancer Targets and Therapy|2017|53